logo

For the Inventor, By the Inventor

Tustin, CA, United States of America

Richard Yee

This inventor holds 7 USPTO granted patents. Top assignee: Allergan, Inc.. Active years: 2008-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Yee. Retrieved from https://idiyas.com/inventor/richard-yee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal7 out of 2,287 
 
Allergan, Inc.
 patents

Years Active: 2008-2016

Loading Chart...
7 patents (USPTO):Explore Patents
1. 9321766 - Kinase inhibitors (2016-04-26),
2. 9296747 - Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2 (2016-03-29),
3. 8455529 - Kinase inhibitors (2013-06-04),
4. 8034957 - Kinase inhibitors (2011-10-11),
5. 7915443 - Sulfoximines as kinase inhibitors (2011-03-29),
6. 7692005 - Kinase inhibitors (2010-04-06),
7. 7439371 - Indol kinase inhibitors (2008-10-21),

Title: Top Inventor in Tustin, California

Introduction: David B. Chang is a prominent inventor based in Tustin, California. He has made significant contributions to various fields through his innovative ideas and patents.

Latest Patents: David B. Chang holds several recent patents that showcase his creativity and technical expertise.

Career Highlights: Throughout his career, David has achieved numerous milestones that highlight his dedication to innovation and excellence.

Collaborations: David has worked with various organizations and individuals, fostering partnerships that enhance his inventive pursuits.

Conclusion: David B. Chang continues to be a leading figure in the world of invention, inspiring others with his work and vision.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…